Podcasts about jain

Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today we will be speaking to the distinguished Dr. Rakesh Jain on the topic of Positive Psychiatry. Psych Congress Discount Code: PSYCHROUNDSConference Website: https://www.hmpglobalevents.com/psych-congressCheck out Dr. Jain's podcast “Positive Psychiatry - with Rakesh Jain, MD”Spotify: https://open.spotify.com/show/0Yk8QVD1wnLxMBM4zJDuJ5?si=wpUCJnAqR7qk9CW8gN90sQApple: https://podcasts.apple.com/us/podcast/positive-psychiatry-with-rakesh-jain-md/id1822146163Sources:- WHO-5: https://www.who.int/publications/m/item/WHO-UCN-MSD-MHE-2024.01- Demyttenaere et. al (2015): https://pubmed.ncbi.nlm.nih.gov/25545606- Dr. Jain's website: http://www.rakeshjainmd.com/

Healing ourselves starts from within. And when we tap into our consciousness, we can heal ourselves in ways that rival traditional medical practice. Today's guest is Dr. Shamini Jain, a scientist, psychologist, author, and teacher of healing and integrative medicine. She'll teach us how the mind, body, emotion, social, interpersonal, and even environmental connections that we have as human beings are incredibly powerful in fostering healing. She shares her research and clinical studies about how moving energy through the body with practices like breathwork, meditation, tai chi, and yoga can reduce inflammation and stress, and help us find wholeness within ourselves. There's actually not a big divide between science and spirituality, and with the help of Dr. Shamini's research, we're moving closer to being able to measure actual positive outcomes from committing to conscious work. Key Topics/Takeaways: Emotions can affect our physical health [3:03] Calming the sympathetic nervous system to reduce inflammation and stress [8:34] Surrendering as a path to healing [12:26] Skepticism and cognitive dissonance in spiritual and scientific studies [15:08] Enhancing our mind-body-energy connection through conscious healing [24:09] Exploring the biofield in cells and the body [28:03] Placebo effect misconceptions [36:48] Episode summary [51:31] About Dr. Shamini Jain: Shamini Jain, PhD, is a scientist, psychologist, author and teacher. She is the founder and CEO of the nonprofit Consciousness and Healing Initiative (CHI), a collaborative accelerator of scientists, healers, artists, and educators to help lead humanity to heal themselves. She received her BA degree in Neuroscience and Behavior from Columbia University and her Ph.D. from the UCSD/SDSU Joint Doctoral Program in Clinical Psychology with a research focus in psychoneuroimmunology. She has received numerous awards for her published research studies in integrative health approaches, including biofield healing and meditation. Her award-winning book with Sounds True Publications, “Healing Ourselves: Biofield Science and the Future of Health '', is available at booksellers worldwide. Dr. Jain integrates her background in clinical psychology, psychoneuroimmunology, healing arts, vocal performance and East Indian spiritual practice to share with others how they can best heal themselves and live joyful, meaningful lives. Shamini speaks and teaches in diverse venues including TEDx, universities, conferences, hospitals and retreat centers.   Learn more and connect with healing resources at https://www.shaminijain.com/ and www.chi.is. Find more from Shamini: TEDx Berkeley: We're Wired To Heal Each Other: The Science of Interconnection (www.tinyurl.com/wiredtoheal) Book with Sounds True Publications: Healing Ourselves: Biofield Science and the Future of Health (www.healingourselvesbook.com) Free Meditation from Shamini Jain:

This podcast episode features a showcase of insights from Nick Jain, the CEO of IdeaScale, who articulates the critical necessity of innovation within organizations. He underscores that without a commitment to innovative practices, businesses risk stagnation, particularly in a competitive landscape where rivals continuously strive for advancement. Throughout the discourse, Jain emphasizes the merits of bootstrapping, detailing how IdeaScale has thrived over the past 15 years without external capital, thereby preserving its autonomy and focus on sustainable growth. He offers three pivotal strategies for aspiring entrepreneurs: maintaining a vigilant awareness of cash flow, judiciously allocating marketing expenditures, and ensuring that every investment yields a tangible return. My aspiration is that listeners glean at least one actionable takeaway from Jain's experiences, which they may readily apply to their own entrepreneurial journeys.The podcast delves into the intricacies of bootstrapping a business, specifically through the lens of Nick Jain, the CEO of IdeaScale, a prominent innovation software company. Jain articulates the vital significance of innovation within organizations, asserting that stagnation inevitably leads to decline. He emphasizes the necessity for continuous improvement, outlining the competitive landscape wherein failure to innovate equates to being outpaced by rivals. IdeaScale's journey, marked by unwavering commitment to sustainable business practices without reliance on external funding, serves as a testament to the efficacy of strategic decision-making and fiscal prudence. Jain reflects upon the duality of challenges and triumphs experienced during their bootstrapping endeavor, acknowledging moments where external capital could have catalyzed growth yet simultaneously recognizing the constraints and pressures accompanying such funding.Takeaways: The importance of innovation in every organization cannot be overstated, as stagnation leads to decline. Bootstrapping a business requires a disciplined approach to financial management and strategic decision making. Understanding and managing cash flows is critical for the sustainability of any bootstrapped enterprise. Marketing expenditures should be scrutinized for their return on investment to ensure effective growth strategies. Continuous learning is essential for personal and professional development, regardless of one's position or industry. A focus on sustainability and cost-effectiveness is vital for long-term success in entrepreneurship. Relevant Links:https://ideascale.com/

Welcome to Top of the Morning by Mint.. I'm Nelson John and here are today's top stories. Whisky, Work Visas & Win-Win Trade After three years of negotiation, India and the UK have inked a landmark Free Trade Agreement, boosting bilateral trade by an estimated $34 billion annually. Signed during PM Modi's London visit, the deal grants duty-free access to 99% of Indian exports, benefiting key sectors like textiles, pharma, and jewellery. Indian consumers gain too—expect cheaper British cars, scotch, chocolates, soft drinks, and medical devices. Beyond goods, the deal opens 35 UK service sectors to Indian professionals for up to 24 months, eliminates social security payments for 3 years, and skips the UK's Economic Needs Test in 36 categories. Commerce Minister Piyush Goyal hailed it as a $23 billion opportunity for India's labour-intensive sectors, and a step toward inclusive growth. From ‘India Out' to ‘India's In' PM Modi landed in Malé for the second leg of his two-nation tour, becoming the chief guest at the Maldives' 60th Independence Day celebrations. This marks a diplomatic reset with President Mohamed Muizzu, whose early tenure saw a tilt towards China and ‘India Out' rhetoric. Key agenda items: maritime security, trade, and inaugurating India-funded infrastructure projects. Several MoUs will be signed, reinforcing the India-Maldives Joint Vision. Foreign Secretary Vikram Misri called it a “significant reset”—a move aimed at rebalancing regional influence. Rubio to Macron: You're Helping Hamas US Secretary of State Marco Rubio lashed out at France for its decision to recognize Palestine at the UN. Calling it “reckless” and “a slap in the face to the victims of October 7,” Rubio claimed the move boosts Hamas propaganda and damages peace efforts. France joins a growing bloc of EU nations supporting Palestinian statehood, while the US maintains that only direct Israel-Palestine talks can lead to a viable two-state solution. The diplomatic divide in the West over Gaza is getting sharper—and more public. Missiles, Fighter Jets & A UN Cry for Help A dangerous escalation between Thailand and Cambodia has left nine civilians dead after Cambodia reportedly launched rocket attacks into Thai territory. In response, Thailand deployed six F-16s, with at least one conducting airstrikes inside Cambodia. Both sides are now trading barbs and expelling diplomats. Cambodia is calling for an emergency UN Security Council meeting, while China has urged restraint. Thailand has sealed borders, begun civilian evacuations, and accused Cambodia of using human shields and targeting hospitals. The baht slipped 0.3% amid rising market anxiety. This conflict could spiral fast. MSME Stress Clouds ₹4,765 Cr Profit Bajaj Finance posted a solid 22% jump in Q1 profit to ₹4,765 crore, but beneath the numbers is a growing concern: stress in unsecured MSME loans. Vice Chairman Rajeev Jain flagged over-leverage as a “single univariate pain point.” Loan loss provisions rose 26%, and restructured loans surged to ₹219 crore—five times the usual. 13 out of 17 MSME sectors are slowing or contracting, with even doctors under strain. Gross NPAs rose to 1.03% (from 0.86% last year), and credit costs may hover near 2% for FY26. While AUM may grow 15%, disbursements will likely remain flat or decline. Recovery, Jain warned, may take “another quarter or more.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Singapore has come a long way since the 1880s, when only roughly 7% of its native forests remained. Since the 1960s, when the city-state gained independence, it has implemented a number of urban regreening initiatives, and today, nearly 47% of the city is considered green space, providing numerous benefits to human residents and wildlife, like heat mitigation, freshwater conservation and cleanliness, carbon sequestration, coastal climate adaptation, biodiversity protection, and public enjoyment. To discuss his city's regreening efforts — from the philosophical to the practical applications of methods and mindset shifts that have allowed the city to revitalize its urban wildlife interface — Anuj Jain, director and principal ecologist at the biomimicry consultancy bioSEA and an adviser to BirdLife International, joins Mongabay's latest podcast. “ Through the greening initiatives in Singapore, it's attracted a lot of species, many of which actually had declined before, some even had gone extinct, or locally extinct,” Jain says. Subscribe to or follow the Mongabay Newscast wherever you listen to podcasts, from Apple to Spotify, and you can also listen to all episodes here on the Mongabay website. Please send questions, feedback or comments to podcast[at]mongabay[dot]com. Image Credit: Supertree grove is part of the Gardens by the Bay (GBTB) urban park in Singapore, covering 105 hectares (260 acres). Image by Tien Tran (tientran0019) via Pixabay (Pixabay Content License). -- Timecodes (00:00) Making the ‘city in a garden' (10:01) What Singapore looks like today (13:51) The many benefits of urban greenery (20:53) Ecology and biomimicry design (24:30) Cleaner, more plentiful water (25:55) Urban regreening in the Middle East (29:16) To densify, or not to densify? (33:04) Where Singapore still struggles (36:33) Living more harmoniously with wildlife

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Ari Paparo talks with Nikhil Jain, VP of Insights and Marketing Solutions at Dailymotion Ads, about the company's work around attention as both a measurement and planning tool. The discussion covers how attention is defined, how it's being predicted through AI and modeling, and the role of creative analysis, inventory quality, and sentiment in shaping campaign outcomes. Jain also shares how Dailymotion is applying video-level analysis, from visuals to audio and text, to support more informed targeting and media planning. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Root Cause Medicine Podcast, Dr. Kate Kresge is joined by Dr. Jessica Christie, a licensed naturopathic doctor, clinical nutritionist, and integrative fertility expert, to discuss a diagnosis that frustrates both patients and practitioners: unexplained infertility. Dr. Christie explains that “unexplained” can sometimes mean “we haven't found the root cause yet,” and she walks us through six of the most common hidden causes of fertility struggles—from subclinical hypothyroidism and nutrient deficiencies to autoimmune markers and environmental toxin exposure. Whether you're a patient searching for answers or a practitioner looking for a more complete workup, this conversation offers evidence-based strategies, powerful case examples, and a hopeful message: unexplained doesn't mean unsolvable. You'll hear them discuss: - Why “unexplained infertility” is a diagnosis of exclusion—and what it often misses (Abdallah et al., 2020) - Six common, often-overlooked root-cause contributors to fertility struggles - How research links subclinical hypothyroidism with IVF success rates (Cho et al., 2015) - The immune markers linked to miscarriage and implantation failure (Demir et al., 2009; Shahbazi et al., 2019; Sauer et al., 2010; Jalilvand et al., 2023; Edassery et al., 2010) - Why gut and vaginal dysbiosis matter for egg quality and implantation (Patel et al., 2022; Tersigni et al., 2014; Blancafort & Llácer, 2023) - The micronutrients most essential for fertility—and most commonly deficient (Skoracka et al., 2021; Ji et al., 2023) - How to approach detoxing safely when trying to conceive (Jain & Singh, 2022; Pizzorno, 2017; NCCIH, 2019) - Real patient stories that show what's possible with root-cause medicine

The engineering field is getting increasingly competitive. How do you stand out as an engineering student today? Jyoti Jain believes the best way is to create a stellar engineering maker portfolio. Jyoti is the Founder of Jain College Consulting. She found her passion for college counseling while helping her own child through the college admissions process. Hear why engineering students should consider submitting an engineering maker portfolio, the key components involved, how to tailor your portfolio to the audience, where engineering students can find meaningful experiences outside the classroom, and why you don't need expensive tools or big projects to make your portfolio shine. Connect with Jyoti at JainCollegeConsulting.com, on LinkedIn, and check out her article on Guiding Students in Creating a Stellar Engineering Maker Portfolio, and Subscribe to College Bound Mentor on your favorite podcast platform and learn more at CollegeBoundMentor.com

Today my guests are legal scholars Chitrakshi Jain and Prashant Reddy T, the authors of the recent book Tareekh pe Justice, Reforms for India's District Courts. We talked about the dysfunction in India's lower courts, opacity in the evaluation of district court judges, the problems with judicial data, and much more. Recorded July 1st, 2025. Read a full transcript enhanced with helpful links. Connect with Ideas of India Follow us on X Follow Shruti on X Follow Chitrakshi on X Follow Prashant on X Click here for the latest Ideas of India episodes sent straight to your inbox.

Rishabh Jain, the co-founder and CEO of FERMÀT, shares his story from the realm of solid-state physics to spearheading innovation in commerce technology in this episode. The conversation goes into how FERMÀT's groundbreaking solutions harness the power of generative AI and large language models to revolutionize customer experiences by emphasizing behavioral data over mere identity data. With notable collaborations alongside industry giants, Rishabh uncovers the intricate art of personalization, the profound impact of AI-driven searches, and the ever-evolving landscape of consumer behavior.  He provides strategies on crafting personalized customer journeys and highlights the pivotal role of GEO search engines in transforming online shopping. The discussion also underscores the urgent need for brands to revamp content strategies for effective interactions with large language models, showcasing the potential of AI in reshaping the future of e-commerce. Show Highlights: Exploration of how FERMÀT's Commerce Brain Data utilizes generative AI and LLMs to enhance customer experiences The shift from identity-focused data to a blend of identity and behavioral data for deeper consumer insights. Importance of personalization and context in consumer engagement. The evolving landscape of GEO searches and their impact on consumer behavior and site experiences. AI's role in transforming traditional recommendation engines and creating personalized site journeys. Follow and Review: We'd love for you to follow us if you haven't yet. Click that purple '+' in the top right corner of your Apple Podcasts app. We'd love it even more if you could drop a review or 5-star rating over on Apple Podcasts. Simply select “Ratings and Reviews” and “Write a Review,” then a quick line with your favorite part of the episode. It only takes a second, and it helps spread the word about the podcast. Supporting Resources: Rishabh Jain: LinkedIn - https://www.linkedin.com/in/rishabhmjain/ | FERMÀT - https://www.fermatcommerce.com/  Learn more about Agentforce for Commerce: https://www.salesforce.com/commerce/ai/  Join the Commerce Cloud Community Unofficial Slack: https://sforce.co/commercecrew *** Episode Credits If you like this podcast and are thinking of creating your own, consider talking to my producer, Emerald City Productions. They helped me grow and produce the podcast you are listening to right now. Find out more at https://emeraldcitypro.com. Let them know I sent you.

What sets a legend apart from just another player? The answer lies in the mind.In this episode, Tara dives deep into the psychology of peak performance with Dr. Samir Parikh and Divya Jain, authors of The Champion Within. What really makes someone a champion, not just in sport, but in life and work?From game-day rituals and comeback stories to dealing with pressure, anticipatory anxiety, and failure, this episode is packed with stories and science behind how mental strength is built.You'll hear about the famous Wimbledon choke that turned into a redemption arc, what athletes do between points to reset their focus, and how a sense of fun can literally shift your performance. Whether you're building a startup, sitting for exams, or chasing your next big win, this episode will make you rethink what it means to show up with grit and joy._____________________________________________________________________________The Bound Publishing Course is a comprehensive, three-month-long, certified program designed to give people the skills, network, and opportunity to build a career in book, magazine, or digital publishing.You will take part in 100 hours of live online sessions, led by over 40 experienced industry professionals. The course moves from foundational learning to specialised career tracks through live simulations, in-class exercises, and assignments. This hands-on approach is supported by career-focused guidance, such as resume workshops and interview preparation, and culminates in a Capstone Project.You can explore more about the course here.Apply here!‘Books and Beyond with Bound' is the podcast where Tara Khandelwal and Michelle D'costa uncover how their books reflect the realities of our lives and society today. Find out what drives India's finest authors: from personal experiences to jugaad research methods, insecurities to publishing journeys. Created by Bound, a storytelling company that helps you grow through stories. Follow us @boundindia on all social media platforms.

In this episode, Lisa and Jyoti discuss:Evaluating college programs for women pursuing STEM degreesThe impact of institutional culture and faculty representation on female STEM persistenceThe role of clubs, communities, and scholarships in STEM success for womenTools and strategies for in-depth college research for female STEM studentsKey Takeaways: Female representation among STEM faculty and mentors significantly improves persistence and confidence in women students by providing relatable role models actively involved in research and mentorship.Programs and colleges that intentionally prioritize gender equity through hiring, admissions goals, and targeted initiatives can offer a more welcoming and empowering environment for women pursuing STEM fields.Supportive ecosystems such as student clubs, professional organizations, and gender-focused learning communities create a vital sense of belonging and peer encouragement that helps women navigate male-dominated disciplines.Early and intentional exposure to hands-on STEM experiences, from middle school through college internships and fellowships, is essential in nurturing both curiosity and long-term career success for young women in science and engineering. “Having women role models to look up to for younger women makes it a little less intimidating.” – Jyoti JainAbout Jyoti Jain: Jyoti found her passion for college counseling while helping her own child through the college admissions process and decided to pursue a Certificate in Career Planning and College Counseling from UC Berkeley Extension.She specializes in STEM, Engineering, and the Pre-Med track. She believes that college is all about fit and is excited about empowering students in discovering their unique STEM journeys.Episode References:#123 College Institutional Priorities: Understanding Who Gets In with Aly Beaumont#132 Computer Science and STEM Admissions Tips with Jyoti JainCommon Data Set InitiativeThe College Finder Fifth Edition by Dr. Steven R. AntonoffGet Lisa's Free on-demand video: How-to guide for your teen to choose the right major, college, & career...(without painting themselves into a corner, missing crucial deadlines, or risking choices you both regret).flourishcoachingco.com/video Connect with Jyoti:Facebook: https://www.facebook.com/jyoticollegeconsultantLinkedIn: https://www.linkedin.com/in/jaincollegeconsulting/Website: https://jaincollegeconsulting.com/Connect with Lisa:Website: https://www.flourishcoachingco.com/YouTube: https://www.youtube.com/@flourishcoachingcoInstagram: https://www.instagram.com/flourishcoachingco/LinkedIn: https://www.linkedin.com/company/flourish-coaching-co

Advisors are drowning in meeting prep, notes and follow-ups—but what if artificial intelligence could give them those hours back and make their advice more personal? In this episode of The WealthStack Podcast, host Shannon Rosic sits down with Era Jain, CEO and co-founder of Zeplyn, to discuss how they're building AI-native workflows that free up … Read More Read More

In this episode, host Shikha Jain, MD, speaks with Elisabeth Potter, MD, about physicians pushing back against insurance companies, bringing physicians back into positions of autonomy and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Potter 1:41 •    The interview 2:04 •    How did you decide to become a plastic surgeon? What was your path?  2:26 •    How many years do you have to train for plastic surgery? 3:36 •    What kind of physician is your father? […] Did you ever think you wanted to practice in the same field as him? 4:10 •    Can you tell us about what happened that led you to post your recent viral video? 6:11 •    Have you noticed an increase in insurance obstacles lately, or has it always been this way? 8:45 •    When you talk to insurance companies, do you feel like you speak with someone who is qualified to understand these claims? 10:06 •    Other than hiring people to deal with insurance claims, how can we work towards actually driving change in this space? 12:11 •    Jain and Potter on the value of physicians knowing their worth and the cost of their care/procedures. 16:03 •    Jain and Potter on the importance of physician autonomy. 23:21 •    Potter and Jain on the changing national dialogue. 28:48 •    When it comes to direct care models, how would patients be able to get second opinions? 33:53 •    Are you optimistic that we will be able to realistically drive change? 35:37 •    What do you suggest physicians, patients and advocates do to raise their voices and be heard? 35:56 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 40:14 •    How to contact Potter 40:41 •    Thanks for listening 41:38 Elisabeth Potter, MD, is a board-certified plastic surgeon offering a variety of plastic surgery, ranging from breast reconstruction to breast and body cosmetic procedures. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Potter can be reached on Instagram @drelisabethpotter, TikTok @drelisabethpotter and YouTube @DrElisabethPotterMD. Disclosures: Jain and Potter report no relevant financial disclosures. 

For years, disease diagnosis and treatment have focused on a few biomarkers, overlooking thousands of vital biological signals. Despite biotech advances, most therapies are still based on limited data, missing countless breakthroughs.Multiomics changes that. By analyzing tens of thousands of proteins, metabolites, and lipids, it reveals hidden insights, paving the way for smarter, faster, and more effective medical discoveries.In this must-listen episode, David Brühlmann welcomes Mo Jain, founder and CSO of Sapient, a pioneering force in bringing multiomic platforms out of academia and into the heart of drug development. A physician-scientist by training and a visionary entrepreneur by choice, Mo's journey spans decades at the cutting edge of analytical technologies, culminating in the creation of ultra-high-throughput systems that analyze up to 20,000 biomarkers in a single run for real-world impact.Here are three reasons why this episode needs to be on your playlist:Multiomics at Scale: Mo shares how his team at Sapient turbocharged mass spectrometry, enabling simultaneous measurement of thousands of molecules, transforming routine diagnostics and making previously unimaginable insights accessible to scientists everywhere.Turning Data into Action: Generating vast data is only half the battle. Mo explains how Sapient developed advanced biocomputational teams and frameworks to extract actionable answers, guiding drug developers to faster, smarter decisions and helping avoid the pitfalls that cripple so many omics projects.The Future Is Personalized and Sooner Than You Think: From dramatically earlier disease detection to truly personalized therapies, Mo paints an optimistic picture of a coming era where AI, multiomics, and new therapeutic modalities rapidly accelerate both discovery and delivery, reshaping how biotech companies tackle even the toughest diseases.Ready to break out of the 20-biomarker rut and see what 20,000 data points can reveal? Tune in to discover how you can harness multiomics in your own research and hear Mo's advice for scientists and entrepreneurs venturing beyond the bench.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

What if the secret to truly personalized precision medicine lies not in your genetic code, but in your zip code?For years, biotech has focused on genomics to explain disease and drug response, but DNA only accounts for a fraction of the story. The real breakthrough? Multi-omics: the large-scale analysis of proteins, metabolites, and lipids, powered by advanced mass spectrometry and AI, offering a fuller picture of human health.In this episode, David Brühlmann meets Mo Jain, founder and CSO of Sapient, a leader in multi-omics analytics. With over two decades of experience across physiology, biomedicine, and computational biology, Mo has been at the forefront of developing scalable multi-omics technologies that are changing the way we predict, diagnose, and treat disease. From leading an academic lab to building a pioneering biotech company, Mo's journey reflects a passion for uncovering the hidden 80–90% of disease risk that lies beyond our genes.Here are three reasons you'll want to listen to this episode:Your Environment Matters More Than Your Genes: Mo explains why your zip code is a stronger predictor of your health than your genetic code, challenging the industry's long-held beliefs and opening new avenues for disease prevention and risk assessment.Multi-omics Disrupts Drug Development: Discover how integrating thousands of biological data points can revolutionize drug discovery by identifying novel targets, better predicting drug response, and accelerating therapeutic breakthroughs that were previously out of reach.Big Data Finally Becomes Actionable: Thanks to rapid advances in mass spectrometry and computational power, scientists can now make sense of overwhelming volumes of multi-omic data, turning what was once information overload into actionable insights for diagnostics and drug development.Ready to think beyond your genes? The biotech revolution is here, and it starts in your neighborhood.Connect with Mo Jain:LinkedIn: www.linkedin.com/in/mo-jain-md-phd-373895baWebsite: www.sapient.bioCompany LinkedIn Page: https://www.linkedin.com/company/sapientbioNext step:Book a free consultation to help you get started on any questions you may have about bioprocessing analytics: https://bruehlmann-consulting.com/callDevelop bioprocessing technologies better, faster, at a fraction of the cost with our 1:1 Strategy Call: The quickest and easiest way to excel biotech technology development. Book your call at https://stan.store/SmartBiotechSupport the show

In this inspiring and thought-provoking episode, we sit down with peace activist, former Jain monk, and ecological visionary Satish Kumar to explore the profound power of Radical Love—the focus of his latest book.Together, we dive into how love can be understood not just as a personal feeling, but as a systemic force capable of transforming families, communities, and entire societies. Satish shares his reflections on how love can shape education, economics, politics, healthcare, and environmental action—offering a bold invitation to reimagine social systems rooted in compassion, care, and connection.From his early life in India to walking thousands of miles for peace, Satish brings rich personal stories and deep wisdom about how love, empathy, and interdependence can heal both people and the planet.Tune in for an exploration of:The role of love in shaping resilient families and communitiesHow Radical Love challenges dominant systems of power, economics, and politicsPractical ways to cultivate love in social action, education, and daily lifeThe intersection of love, justice, and sustainabilityWhy love must become a guiding principle for systemic changePrepare to be moved, challenged, and inspired.Radical Love (2023)https://shop.resurgence.org/product/view/REBK111/radical-loveTo see peace in our lifetimes, we have to practise love.This is the radical message of this inspirational book of pithy advice from environmental activist Satish Kumar, which helps us find ways to love ourselves, others, and all beings on planet Earth—even those we may find unlovable.Satish Kumar is well known for his epic walk for world peace in his youth in the 1960s from India to the nuclear capitals of Moscow, Paris, London, and Washington, DC. Wherever he traveled, he found that human beings were capable of a love that could overcome hatred and division. Settling down in the UK, he married his wife, June Mitchell, and founded eco-university Schumacher College in Devon, eventually becoming a leading figure in the UK green movement.Radical Love distills the author's lifetime of experience as a lover, parent, activist, and educator into simple lessons on transforming our time of ecological crisis, conflict, and scarcity into one in which we experience harmony with nature, safety, and abundance. It is an exploration of the transformative power of love in all its forms, from romantic love to love for one's family and community to love for the planet and all beings.Kumar's approach is founded on simplicity (including the Jain principle of aparigraha), generosity, and continuous learning. Like an unfolding metta meditation, the book expands our notions of love to its most sublime universal state and makes a great gift to share with those we love.

Today I am chatting with Aashita Jain,About the privacy career she maintains.Aashita used to live in Bangalore,We will talk about Informatica and all the jobs she had before!

Today, Ali is talking to Dr. Nirali Jain, a Reproductive Endocrinologist at RMA, about the importance of fertility preservation for cancer patients. "I do feel like the system failed us a little bit, and I tell all my patients when they come in for their first visit, your entire life, you learned how to not get pregnant, and you never thought you'd be sitting in this office learning about timed intercourse and figuring out when you're ovulating," Dr. Jain says. Ali and Dr. Jain talk about how chemo can affect fertility, what your options are when you get a cancer diagnosis, and how to get a referral to a fertility specialist from your oncologist. If you or anyone you know has recently been diagnosed with cancer and you're interested in preserving your fertility, this is a must listen! Spread the word!  Follow Dr. Jain on IG: @eggspert_mdTOPICS COVERED IN THIS EPISODE: Cancer; chemotherapy; chemo agents; egg quality; egg freezing; embryo freezing; advocacy; trying to conceive; timed intercourse; ovulation EPISODE SPONSORS: BEAUTIFUL BIRD AND WORK OF ARTAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “Beautiful Bird” tells the story of three parents, one incredible boy and a family built with love—and a little bit of science.Pre-orders are available now! The first 150 copies will be Personalized, Signed and Numbered! Don't miss out on this limited edition! Tap the link in bio and stories to order your copy today.When Helen decides to have a baby on her own, she welcomes Jack Bird into the world through IUI with the help of her friend, Aaron. But when Jack is born and needs extra care in the NICU, Aaron and his partner, Blake, fall in love with Jack, too. Together, the three join forces to raise Jack, proving that family isn't about how you start—it's about how you grow.Order yours now at https://www.infertileafgroup.com/booksFor bulk orders of 10 or more books at 20% off, go to https://www.infertileafgroup.com/bulk-order-requestFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipGENERATIONS CRYOVAULTwww.gencryo.comIG: @generationscryovaultWhen you're navigating fertility treatments, every decision feels big—because it is big. But did you know that when it comes to storing your reproductive tissue—including eggs, sperm, and embryos—you DO have a choice? Most clinics automatically store your tissues—or hand you off to their partner. But guess what? It doesn't have to be that way. Enter Generations CryoVault, which believes in the motto, "Your tissues. Your choice." When you choose to work with Generations CryoVault, they help you transfer your tissues securely and easily to their headquarters – a place you can trust. Take control of this part of your journey by visiting gencryo.com. And make sure to mention Infertile AF to receive 1 free month of storage.Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacySupport this podcast at https://redcircle.com/infertile-af/donationsOur Sponsors:* Check out Happy Mammoth and use my code INFERTILEAF for a great deal: https://happymammoth.comSupport this podcast at — https://redcircle.com/infertile-af/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

In this episode of Grownlearn, I'm joined by Nick Jain, founder of Content Hurricane, an AI-powered content engine that's changing how startups and small businesses scale their organic traffic. Nick shares how early users of his platform saw 80%+ increases in inbound leads in just 10 weeks, and how one of his own brand-new domains shot to the top 0.1% of all new websites on Google — in just 4 weeks. We go deep on: Why traditional SEO is dying (and what's replacing it) How Content Hurricane creates high-quality, evergreen blog posts using AI Real-world strategies for scaling inbound traffic The future of SEO, AI-generated content, and business growth If you're building a startup, scaling a business, or want content that actually drives results — this is a must-listen. Try Content Hurricane (Beta)

Ed Parcaut welcomes Nick Jain, CEO of IdeaScale, to the Inner Edison Podcast for an inspiring conversation about entrepreneurship, leadership, and innovation. Hear Nick share his compelling journey from humble beginnings as the child of Indian immigrants in Canada to hedge fund investor on Wall Street, and ultimately to turnaround CEO for multiple companies. Nick dives deep into the lessons learned from his upbringing, the immigrant work ethic, and how becoming a new parent has changed his perspective on life and business. Discover how Nick transitioned from Wall Street to running large organizations, why understanding the numbers is key for any business, and how using AI tools like ChatGPT is transforming productivity at IdeaScale. If you're a business owner, entrepreneur, or just passionate about innovation, you'll get actionable insights on eliminating waste, building metrics-driven teams, and using technology to scale. Nick also discusses IdeaScale's mission—to help organizations of any size harness the power of collaborative ideas—and shares how you can start innovating for free. Whether you're running a one-person shop or a global corporation, this episode is packed with practical wisdom to help you grow and future-proof your business. Connect with Nick on LinkedIn or try IdeaScale at ideascale.com. **Contact Ed Parcaut:** -

In this episode of FinTech Impact, host Jason Pereira talks with Era Jain, co-founder and CEO of Zeplyn, about how her company is transforming the wealth management industry through AI-powered automation. Zeplyn aims to streamline the cumbersome and time-consuming tasks associated with client meetings for financial advisors, thereby allowing them to focus more on client relationships and growth activities. Jain shares the origin story of Zeplyn, their innovative approaches to integrating AI into financial workflows, and their vision for the future, including client and practice intelligence. The episode also touches on the challenges and successes of implementing AI in an industry that often relies on outdated technology. Hosted on Acast. See acast.com/privacy for more information.

Madhavi Jain joins us today to talk about Connected Capital, getting better splits, more access to better deals, and her multifamily journey.----Continue the conversation with Brian on LinkedInJoin our multifamily investing community with like-minded apartment investors at the Tribe of TitansThis episode originally aired on June 27, 2025----Watch the episode on YouTube: https://www.youtube.com/channel/UCcsYmSLMxQCA9hgt_PciN3g?sub_confirmation=1 Listen to us on your favorite podcast app:Apple Podcasts: https://tinyurl.com/AppleDiaryPodcast Spotify: https://tinyurl.com/SpotDiaryPodcast Google Podcasts: https://tinyurl.com/GoogleDiaryPodcast Follow us on:Instagram: https://www.instagram.com/diary_of_an_apartment_investor Facebook: https://www.facebook.com/DiaryAptInv/ Twitter: https://twitter.com/Diary_Apt_Inv ----Your host, Brian Briscoe, has owned over twenty apartment complexes worth hundreds of millions of dollars and is dedicated to helping aspiring apartment investors learn how to do the same. He founded the Tribe of Titans as his platform to educate aspiring apartment investors and is continually creating new content for the subscribers and coaching clients.He is the founder of Streamline Capital based in Salt Lake City, Utah, and is probably working on closing another apartment complex in the greater SLC area. He retired as a Lieutenant Colonel in the United States Marine Corps in 2021 after 20 years of service.Connect with him on LinkedIn----Madhavi JainMadhavi is the President, Wealth strategist and a Podcast Host at Think Outside the Stocks, which is now recognized as Top 3% podcast globally.Madhavi helps her clients with a two-fold approach to Grow, Preserve, Protect and Pass generational wealth. An efficient savings vehicle with Infinite Banking and risk-managed investing in commercial real estate syndications. She is a passive investor coach and brings high quality investments to her clients via historically recession resistant asset classes such as multi family, self storage, industrial, senior assisted living, and more. Prior to her real estate exploration, Madhavi spent 16+ years in the IT industry mostly with one of the top 5 consulting firms and with her exit from the corporate world, she is now on a mission to “Change the financial trajectory of one family at a time and thousands more to go."Learn more about her at:https://www.linkedin.com/in/madhavinadejain/,https://thinkoutsidethestocks.com/, or  Podcast: https://rb.gy/kvrn4v

In this episode, host Shikha Jain, MD, speaks with Don Dizon, MD, about innovation throughout times of uncertainty in medicine, challenges currently facing physicians and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Dizon 1:44 •    The interview 2:27 •    How did you decide to become an oncologist and navigate a traditional academic career with many non-traditional “add-ons”? 3:01 •    Jain and Dizon on the importance of providing humanity to physicians. 7:19 •    Jain and Dizon on finding balance when providing patients with information.  9:03 •    Jain and Dizon on federal funding challenges facing oncology advancements.  10:17 •    Can you tell us more about transitioning to your new role at Tufts? 12:50 •    Jain and Dizon on the growing amount of career shifts in medicine. 17:22 •    How do we move forward with these new guardrails up from corporatization? 18:34 •    Jain and Dizon on how the age of social media has changed the perception, training and demands of doctors. 24:56 •    Dizon and Jain on the power of being able to admit “I don't know.” 28:22 •    What are some tips that you have for new attendings and people just starting in their careers? 33:54 •    Dizon and Jain on the importance of humanizing patients during their care. 38:34 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 44:17 •    How to contact Dizon 44:57 •    Thanks for listening 45:51 Don Dizon, MD, is a professor of medicine at Tufts University and is the system chief of hematology and oncology for Tufts Medicine. He is also the editor in chief of CA: A Cancer Journal for Clinicians, the flagship journal of the American Cancer Society as well as the vice-chair of membership and accrual at the SWOG Cancer Research Network. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dizon can be reached on Tiktok @drdonsdizon, Instagram @drdonsdizon and LinkedIn.  Disclosures: Jain and Dizon report no relevant financial disclosures. 

Surgical techniques in gynecology vary widely between surgeons, creating both excitement and frustration for residents trying to learn the "right way" to perform procedures. Howard and guest host Maddie White discuss this and more:• Trocar placement during laparoscopy requires careful consideration of patient factors and potential adhesions• Elevating the abdomen during trocar placement remains standard practice, though definitive evidence on its necessity would require studies of over 100,000 patients• Surgeons should understand power analysis to recognize when studies are underpowered to detect meaningful differences in rare complications• Visceral slide technique using ultrasound can identify adhesions and determine the safest entry point for laparoscopic surgery• Palmer's point may no longer be the safest entry point for many patients given the prevalence of bariatric surgeries• Jain's point (lateral to the umbilicus) may now be statistically safer for many patients with complex surgical histories• Vaginal cuff dehiscence rates are 6-10 times higher with laparoscopic/robotic hysterectomy compared to vaginal approaches• The higher dehiscence rate stems from using energy devices for colpotomy rather than cold scalpel techniques• Barbed sutures simplify cuff closure but don't reduce dehiscence rates compared to standard suturing techniques• Surgery consists of "a thousand little things done well" - mastering these micro-skills distinguishes excellent surgeons00:00:00 Surgical Techniques: Excited and Frustrated00:08:00 Elevation During Trocar Placement 00:17:00 Evidence and Power Analysis00:21:35 Visceral Slide Technique00:35:10 Alternative Trocar Entry Points00:40:10 Cuff Closure and Dehiscence Risk00:51:45 Laparoscopic vs Vaginal Colpotomies01:03:00 First Accredited OB-GYN Residency ProgramFollow us on Instagram @thinkingaboutobgyn.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/BFB865. CME/MOC/AAPA credit will be available until June 30, 2026.C3 for CLL: Community Conversations on Modern Care—Implications for Upfront and Sequential Management In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and CLL Society. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from BeOne Medicines and Lilly.Disclosure information is available at the beginning of the video presentation.

This episode features a comprehensive discussion of research examining socially assisted robotics for children with autism. Madeline Jürgensen presents findings from two single-case design studies that investigated whether children with autism would attend to and learn from a small humanoid robot called Kebbi. The first study used a multiple baseline design to measure attending behaviors, revealing dramatic increases in eye contact and engagement when children worked with the robot versus human instructors. The second study employed an adaptive alternating treatment design to compare learning outcomes between robot and human instruction, finding that while children learned academic skills from both modalities, they showed preference for robot-delivered activities despite sometimes performing better with human instruction. The discussion includes important considerations about the novelty effect, social validity, and the future role of robotics in behavior analysis practice.  To earn CEUs for listening, click here, log in or sign up, pay the CEU fee, + take the attendance verification to generate your certificate! Don't forget to subscribe and follow and leave us a rating and review. Show Notes References:   Berens, K. N. (2020). Blind spots: Why students fail and the science that can save them. Oakland, CA: The Collective Book Studio.  Darling, K. (2021). The new breed: What our history with animals reveals about our future with robots. Henry Holt and Company.  Shi, Z., Groechel, T. R., Jain, S., Chima, K., Rudovic, O., & Matarić, M. J. (2022). Toward personalized affect-aware socially assistive robot tutors for long-term interventions with children with autism. Journal of Human-Robot Interaction, 11(4), Article 39. https://doi.org/10.1145/3526111  Resources:   Association for Behavior Analysis International (ABAI): https://www.abainternational.org/  CentralReach Institute: https://centralreach.com/  University of Southern California Robotics and Autonomous Systems Center (RASC): https://rasc.usc.edu/research/    If you would like a copy of the articles discussed please reach out to madeline.jurgensen@centralreach.com

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/literary-studies

In this episode, we sit down with Poonam Jain — an Alchemist Coach, ICF-certified PCC, Energy Healer, and seasoned IT professional with over 22 years of global experience — to explore the powerful intersection of corporate life, entrepreneurship, mindset transformation, and energy work.

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/south-asian-studies

A vast corpus of Jain texts lies unexamined in manuscript libraries, several of them new versions of earlier works. Though the prevalence of literary transcreation in Jain communities is striking, it is by no means a practice exclusive to them. The field of South Asian Studies has increasingly dealt with the creative engagement of authors with an authoritative literary object. Although these studies have brought to the fore important conclusions, the Jains as a literary community have remained absent from these discussions. This volume addresses this gap, highlighting the influential role of Jain authors in the multilingual literary world of South Asia. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/religion

Discover the fascinating journey of Sidharth Jain, founder of The Story Ink, India's leading book-to-screen adaptation company. From his early days as a stock trader to producing the acclaimed Netflix series "Trial by Fire," Jain shares insights on what makes stories screen-worthy, the challenges of adaptation, and how Indian content is evolving in the global streaming era. A must-read for aspiring filmmakers, authors, and anyone curious about the entertainment industry.00:34- About Sidharth JainSidharth is the founder of The Story Ink, which is India's leading book to screen adaptation company.He's also the founder of the House of Talkies, which is a Content Studio.

What if everything you know about Canadian immigration is only half the truth? In this explosive episode, I sit down with Sumit Jain, one of Canada's most trusted immigration professionals, to uncover the real game behind PR, study visas, work permits, and why most people fail—not because of paperwork, but because of bad advice. Whether you're planning to move, already in Canada, or stuck in limbo, this conversation will change how you think about immigration forever.

This week's episode of the podcast is in the MDM Mailbag format. I recruited Rishabh Jain, the CEO of eCommerce experience platform FERMÀT, to answer questions submitted by the MDM community. Among other topics, those questions related to:the "universal truths" of user acquisitiona viable "self-learning path" for acquiring data analytics / data science skillsthe role of technical media buyers going forwardthe purpose of the CMO rolewhat happens if Google is forced to divest part of its Network businessThanks to the sponsors of this week's episode of the Mobile Dev Memo podcast:INCRMNTAL⁠⁠. True attribution measures incrementality, always on.⁠⁠⁠Clarisights⁠⁠⁠. Marketing analytics that makes it easy to get answers, iterate fast, and show the impact of your work. Go to⁠⁠⁠ clarisights.com/demo⁠⁠⁠ to try it out for free.Interested in sponsoring the Mobile Dev Memo podcast? Contact ⁠Marketecture⁠.The Mobile Dev Memo podcast is available on:Apple PodcastsSpotify

This week on A Mental Health Break, we're taking a vital step towards understanding a challenging, yet often overlooked, aspect of mental health. We're honored to welcome Dr. Rakesh Jain, MD, MPH, a distinguished Clinical Professor of Psychiatry at Texas Tech University, and Sherland Peterson, who openly shares her personal journey of living with Tardive Dyskinesia (TD).More than 14 million Americans live with serious mental illness, often treated with antipsychotic medicines. But what happens when treatment leads to another debilitating condition? Dr. Jain will illuminate:What Tardive Dyskinesia (TD) is, its common signs and symptoms, and its profound connection to mental health.The critical findings from the IMPACT-TD study on challenges faced by patients and doctors.A revolutionary one-pill, once-daily treatment option that can integrate seamlessly with existing mental health plans.Sherland will bravely share:Her personal story of living with TD, offering invaluable firsthand insight.The impact TD has had on her daily activities, mental health, and social life.This episode is a crucial conversation for anyone seeking to understand the complexities of mental health treatment, the importance of holistic care, and the power of resilience. Join us for a break that truly educates and empowers.Support the showHave a question for the host or guest? Want their freebee? Are you looking to become a guest or show partner? Email Danica at PodcastsByLanci@gmail.com.This show is brought to you by the Empathy Set and Coming Alive Podcast Production.CRISIS LINE: DIAL 988

Technical brilliance is table stakes. Influence is the multiplier. In this episode, Hakeem Adebiyi sits down with Francie Jain—CEO of Terawatt, the coach-matching platform—to unpack:Google's Project Aristotle: why psychological safety outperforms raw IQA Colorado hospital that saved $32 M per year by embracing group coaching“Opposite-Strengths” teaming: pairing your weakness with someone's superpowerThree quick wins STEM pros can start today to boost executive presenceHow Terawatt lets companies RFP a coach the way you'd book a room on AirbnbHit ▶, then follow the show so you never miss an episode packed with actionable leadership science.

In this episode, recorded live at the 2025 ASCO annual meeting, host Shikha Jain, MD, speaks with Sonali Smith, MD, about the power of mentorship and advocacy, preserving the academic mission of research within health care systems and more. •    Welcome to another exciting episode of Oncology Overdrive 1:34 •    About Smith 1:56 •    The interview 3:14 •    What was your journey to get to where you are now in your career?  3:38 •    How do you incorporate your advocacy work into patient care, and how do you advise other physicians on their advocacy journeys? 12:09 •    Jain and Smith on how the politicization of health care has resulted in the rise of and demand for public physician advocacy.  13:32 •    Jain and Smith on the impacts of today's climate on clinical research work.  18:24 •    Can you speak about your ELAM capstone project discussing how to preserve academics? 25:11 •    Are there any lymphoma studies presented at ASCO this year that have excited you or interested/educated you? 31:54 •    Jain and Smith on how ASCO underlines the importance of international collaboration in oncology research. 36:46 •    If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 39:47 •    How to contact Smith 40:27 •    Thanks for listening 41:03 Sonali M. Smith, MD, is the Elwood V. Jensen professor of medicine, section chief of hematology/oncology, co-leader of the cancer service line, and co-director of the lymphoma program at the University of Chicago in the department of medicine. She is a clinical investigator in lymphoma and a clinical expert in Hodgkin and non-Hodgkin lymphomas. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Smith can be reached on LinkedIn or via email smsmith@bsd.uchicago.edu.  Disclosures: Jain and Smith report no relevant financial disclosures. 

The Harvest Series Podcast returns with a new season!In this episode, Rose Claverie interviews Satish Kumar, a former Jain monk, peace activist, and advocate for simple living. Satish shares the profound lessons he's learned about courage, love, and the importance of embracing the unknown. His personal journey, which includes walking from India to the world's nuclear capitals without money, highlights the human connection that unites us all, regardless of nationality or religion.In an era where conflict seems pervasive, Satish's message is clear: love is the answer to every problem. He talks about the courage required to live authentically, how love can bridge divides, and why peace must start in our hearts. This episode is filled with invaluable insights on how to live a life rooted in courage, simplicity, and compassion. If you want to know more about the Satish Kumar foundation.Chapters 00:00 - Introduction to Satish Kumar 00:30 - The Meaning of Courage 01:00 - Escaping the Monastery: A Moment of Courage 03:00 - The Journey to Find Peace 06:00 - The Importance of Love in Conflict Resolution 09:00 - Walking for Peace: 2.5 Years, 15 Countries 14:00 - Satish's Encounter with Bertrand Russell 18:00 - Bhutan: A Country of Happiness 22:00 - Courage in Relationships: Satish's 40-Year Marriage 25:00 - The Bravest People Satish Has Met 28:00 - Conclusion: A Life of Action, Not AchievementYou can follow us on Instagram at @HarvestSeries or @rose.claverie for updates.Watch our podcast episodes and speaker sessions on YouTube: Harvest Series.Credits:Sound editing by: @lesbellesfrequencesTechnicians in Kaplankaya: Joel Moriasi & teamMusic by: ChambordHarvest Series is produced in partnership with Athena Advisers and Capital PartnersHarvest Series Founders: Burak Öymen and Roman Carel

This episode recorded live at the Becker's 3rd Annual Spring Payer Issues Roundtable features Dr. Sachin Jain, President and Chief Executive Officer, SCAN Group. Dr. Jain discusses how SCAN is redefining member experience through human-centered care and highlights the urgent need for deeper payer-provider partnerships to drive true innovation and better outcomes in healthcare.

On this episode of The Wholesome Fertility Podcast, I am joined by Dr. Nirali Jain (eggspert_md), a board-certified OB/GYN and reproductive endocrinologist at Reproductive Medical Associates (RMA). Dr. Jain shares her expert insights on fertility preservation for individuals undergoing cancer treatment, a crucial yet often overlooked aspect of reproductive care. We explore what options are available for fertility preservation, including egg and sperm freezing, and why it's so important to initiate these discussions before starting chemotherapy or radiation. Dr. Jain also explains the difference between Letrozole and Clomid, the impact of estrogen-sensitive cancers on IVF treatments, and innovative approaches like random-start cycles and DuoStim protocols. Whether you're facing a cancer diagnosis or simply thinking proactively about your reproductive future, this conversation is filled with knowledge and reassurance. Key Takeaways: Why it's essential to discuss fertility before starting cancer treatment. The role of Letrozole in estrogen-sensitive cancers and fertility preservation. Differences between Letrozole and Clomid, and why Letrozole is often preferred. How new protocols like DuoStim and random-start cycles are improving outcomes. Why fertility preservation is important even for those without a cancer diagnosis. Guest Bio: Dr. Nirali Jain (@eggspert_md) is a board-certified OB/GYN and fertility specialist at Reproductive Medicine Associates (RMA) in Basking Ridge, New Jersey. She earned both her undergraduate degree in neurobiology (with a minor in dance!) and her medical degree from Northwestern University, before completing her residency at Weill Cornell/NYP, where she served as co-Chief Resident, and her fellowship in reproductive endocrinology and infertility at NYU Langone. Deeply passionate about women's health and fertility preservation, Dr. Jain blends the latest research and cutting-edge treatments with compassionate, patient-centered care. Her interests include third-party reproduction and oncofertility, and she is especially passionate about supporting patients navigating fertility preservation through a cancer diagnosis. Outside of the clinic, Dr. Jain is a trained dancer, a dedicated global traveler, and an adventurer working toward hiking all seven continents with her husband. Her diverse experiences, from international medical rotations to personal connections with friends and family navigating infertility, have shaped her into a warm, resourceful, and determined advocate for her patients. Links and Resources: Visit RMA websiteFollow Dr. Nirali Jain on Instagram For more information about Michelle, visit www.michelleoravitz.com To learn more about ancient wisdom and fertility, you can get Michelle's book at: https://www.michelleoravitz.com/thewayoffertility The Wholesome Fertility facebook group is where you can find free resources and support: https://www.facebook.com/groups/2149554308396504/ Instagram: @thewholesomelotusfertility Facebook: https://www.facebook.com/thewholesomelotus/ Disclaimer: The information shared on this podcast is for educational and informational purposes only and is not intended as medical advice. Please consult with your healthcare provider before making any changes to your health or fertility care. --  Transcript:   # TWF-Jain-Nirali (Video) ​[00:00:00]  **Michelle Oravitz:** Welcome to the podcast Jain.  **Dr. Nirali Jain:** Thanks so much for having me **Michelle Oravitz:** Yeah, so. **Michelle Oravitz:** I'm very excited to talk about this topic, which, um, actually you don't really hear a lot of people talking about, which is how to preserve your fertility if you're going through a cancer diagnosis and if you have to go through treatments. 'cause obviously that can impact a lot on fertility. **Michelle Oravitz:** I have, um, seen actually like a colleague of mine go through. And she also preserved her fertility and, and now she has a baby boy. so it's really nice. **Michelle Oravitz:** to **riverside_nirali_jain_raw-video-cfr_michelle_oravitz's _0181:** so nice. **Michelle Oravitz:** So I'd love for you first to introduce yourself and kind Of give us a background on how you got into this work. **Dr. Nirali Jain:** Of course. Um, so I am Dr. Narly Jane. I am, um, an OB GYN by training, and then I did an additional, after completing four years of residency in OB GYN and getting board certified in that, I did an additional training in reproductive endocrinology and [00:01:00] infertility or otherwise known as REI. So now I'm a fertility specialist. **Dr. Nirali Jain:** Um, I trained at Northwestern in Chicago, so I went to undergrad and medical school there. And then, um, home has always been New Jersey for me, so I moved back out east to New Jersey. Um, I did all my training actually in New York City at Cornell for residency and NYU for fellowship. Um, and then moved to the suburbs. **Dr. Nirali Jain:** Um, and now I'm a fertility specialist in, in Basking Ridge at Reproductive Medical Associates.  **Michelle Oravitz:** Very impressive background. That's awesome.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** I'd love to hear just really. About what your process is. If a person has been diagnosed with cancer, like what is the process? What are some of the things that you address if they are trying to preserve fertility, and what are some of the concerns going  **Dr. Nirali Jain:** yeah, yeah. All great questions. So, you know, there's a lot of us, uh, the Reis. Are a very small, [00:02:00] there's a very small number of us. So in terms of specializing in fertility preservation, technically we all are certified to treat patients with cancer and kind of move them through fertility preservation before starting chemotherapy. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, luckily we've been working closely with oncologists in the past several years just to establish some type of streamlined system because having a diagnosis of cancer and hearing all that information. Especially when you're young is so hard. So I think that's, that's where my interest started in terms of being able to speak to and counsel cancer patients. **Dr. Nirali Jain:** I think it is a very specific niche that you really have to be comfortable with in our field. Um, I. So I'll kind of walk you through, you know, what it, what does it look like, right? Um, you go into your oncologist's office suspecting that you have this, this lump. I'll take breast cancer, for example. It could really be any kind of cancer. **Dr. Nirali Jain:** Um, but breast cancer in a reproductive age patient or someone that's in those years where you're starting [00:03:00] to think about building a family, planning a family, um, or if you have kids at home, that's usually the type of patient that we see come in with a breast cancer diagnosis. So. Kinda just taking that, for example, um, the minute that you're diagnosed, it's really your oncologist's responsibility to counsel you on what treatment options are going to be offered to you. **Dr. Nirali Jain:** And then based off of the treatment options, it's important to know how that affects your reproduction. So how does it affect your ovaries in the short term, in the long term, um, in any way possible. So. Once a patient is initially referred from their oncologist to myself or any other fertility specialist, they come into my office and we just have a 30 minute conversation really talking about family planning goals. **Dr. Nirali Jain:** Any kids that they've had in the past either naturally conceived or through um, IVF, and then we talk about where they're at in their relationship. Are they married, are they not? Are they with a partner, [00:04:00] a male partner, a female partner, whatever it might be. It's important to know the social standpoint, um, especially in this sensitive phase of life. **Dr. Nirali Jain:** So patient patients usually spend anywhere from 30 minutes to an hour. Um, just kind of talking through where they're at, how they're feeling, what their ultimate childbearing goals are. And then from there we do an ultrasound and that's when I'm really able to see, you know, the, the reproductive status. **Dr. Nirali Jain:** So what do the ovaries look like? What does the uterus look like? Is there something that I need to be concerned about from a baseline GYN standpoint? Um, and all of those conversations are happening in real time. So. I think one of the things is patients come in and they're like, I'm already so overwhelmed with all this information from my oncologist, and now my fertility specialist is throwing all this information at me. **Dr. Nirali Jain:** Luckily, the way I like to frame it is you come in and you just let go. Like you let us do the work because in the background we're the ones talking to your oncologist. We're the [00:05:00] ones giving that feedback and creating a timeline with your oncologist. Um, and really I think just getting in the door is the hardest part. **Dr. Nirali Jain:** So once patients are here to see us, we go through the whole workup. We do anything that we would do for a normal patient that came in for fertility preservation. And then based off of where they're at in their journey, we talk about what makes sense for them, whether that means freezing embryos, freezing eggs, they're very similar in terms of the, the few weeks leading up to the egg retrievals. **Dr. Nirali Jain:** So I have that whole conversation just at the initial visit. And then from there we talk about the timeline behind the scenes and make sure that it works with their lives before moving forward. **Michelle Oravitz:** So for people listening to this, why, and this might be an obvious question, but to some it might not be,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** why would somebody want to preserve. eggs or sperm. 'cause I've had actually some couples  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** come to me where the husband preserved the sperm and they had to go through IVF just because he was going [00:06:00] through cancer treatments. So he had to preserve the sperm ahead of time.  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** people need to consider doing that before doing cancer treatments?  **Dr. Nirali Jain:** So there are certain cancer treatments that do affect the ovaries and the sperm health, and you know, for men and women, it affects your reproductive organs. In a similar way, um, depending on the type of chemotherapeutic agent, there are some that are more dangerous in terms of, um, being toxic to your ovaries or toxic to your sperm. **Dr. Nirali Jain:** And those are the instances where we are really thinking about what's the long-term impact because there's medications that oncologists do give patients, and our oncologists are amazing, the ones that we work with, Memorial Sloan Kettering from Reproductive Medical Associates through RMA, um, and. **Dr. Nirali Jain:** They're just so good at what they do and are so well-trained, so they know in the back of their mind, is this going to impact your ovaries or your sperm health or not? Um, and I [00:07:00] think that any chemotherapy, you know, your ovaries are these, these small organs that are constantly turning over follicles every month. **Dr. Nirali Jain:** So every month we're losing those eggs, and if they don't become. If an egg isn't ovulated, it doesn't become a baby, it's just gonna die off. So I counsel even patients that don't have cancer, I counsel them on fertility preservation as young as possible. You know, between the ages of 28 and 35, that's like the best time to preserve your fertility. **Dr. Nirali Jain:** So in cancer patients, there's an extra level added to that where even if they are a little bit younger, a little bit older. Your eggs are not gonna be the same quality. There's gonna be higher level of chromosomal errors, more DNA breakage, um, and, and bigger issues that lead to issues with conceiving naturally afterwards. **Dr. Nirali Jain:** So I think that it's important to consider how that chemotherapy is going to affect them or how surgery would affect them if it was, for example, a GYN cancer where [00:08:00] we're removing a whole ovary, you know, what, what do we have to do to preserve your fertility in that case? And those are important conversations to have. **Michelle Oravitz:** Yeah. for sure. I know that a lot of people are also concerned, you know, with going through the IVF process, you're taking in a lot of estrogen, a lot of hormones, and many cancers are actually estrogen sensitive. So I wanted to talk to you about that. 'cause I know that the data shows that it's. It's been fine, which some people might find surprising, but I wanted you to address that and just kind of **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** from your perspective.  **Dr. Nirali Jain:** That's so interesting that you asked that question because I actually, my whole I I graduated fellowship last year and my entire, like passion project in fellowship was looking at one of the drugs that we use to suppress the estrogen levels specifically in cancer patients. Um, and I had presented this at a few of our reproductive meetings. **Dr. Nirali Jain:** Um, A SRM is one of our annual meetings where all of the reiss get together. A lot of male fertility [00:09:00] specialists come and we kinda just talk about. Specific things and fertility preservation for cancer patients is, has been an ongoing topic of interest for all of us. Um, and it's important to know that there are different medications that we can offer. **Dr. Nirali Jain:** Letrozole is the one that I, um, have a particular love for and I, uh, you know, I use all the time for my patients, um, for different reasons, but it suppresses the exposure that your body has to estrogen. And there's mixed data, um, out there in terms of, you know, does Letrozole suppression actually impact, you know, does it help or. **Dr. Nirali Jain:** Or does it have no impact on your future risk of cancer after treatment? Um, and that honestly is still up for debate. But what we do know is that there's no increased risk of cancer recurrence in patients that have undergone fertility preservation with or without Letrozole. Um, Letrozole is one of those things that we can give, and the way it works is basically. **Dr. Nirali Jain:** It masks that [00:10:00] conversion. It, it doesn't allow for conversion from those androgens in the male hormones over to estrogen. Um, and so your body doesn't really see that estrogen exposure. It stays nice and low throughout your cycle, and it does help with actually ovarian maturation and getting mature eggs harvested and, um, helps a little bit with, with quality too. **Dr. Nirali Jain:** So I think that it's really nice in terms of having that available to us, but know that. It's not, it's not essential that you have it, really, the data showing plus minus. Um, but there are certain things that we can do to protect the ovaries, protect your exposure to estrogen. Um, and so that shouldn't be top of mind of concern when we're going through fertility preservation, even with an estrogen sensitive cancer. **Michelle Oravitz:** Actually, so, uh, on a different topic, kind of going back to that, so Letrozole versus Clomid, I, it's like a, the questions I personally feel just based on what I've heard and like my own research that Letrozole would be kind of like the more. [00:11:00] Um, the, it's, it's a little better, but I know that it really depends on the person as well.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** they might do better with Clom, but I'd love to hear your perspective and kind of pick your brain on this.  **Dr. Nirali Jain:** totally. You're choosing all the, all the right questions because these are all of my, my specific interests and niches. So  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** Letrozole is basically, you know, we use Letrozole and Clomid in. Patients that don't have cancer and patients that come in for an intrauterine insemination, that's kind of the most common scenario where we're thinking about, you know, which medication is better? **Dr. Nirali Jain:** Letrozole or Clomid and Clomid used to be the, the most common medication that we use, we dose patients, you know, have 50 milligrams of Clomid, give them five days of the medication. It's an oral pill. Feels really easy and. The way it works is really, it recruits more than one follicle, so it really helps with the release of, um, more than one follicle growing more than one follicle in the ovary. **Dr. Nirali Jain:** Um, but it has a little bit [00:12:00] higher of a risk of twins because that's exactly what it's good at. Um, Clomid, not so much in the cancer. In the cancer front, it's not really used there because it's considered, from a scientific perspective, it's considered like a selective estrogen receptor modulator. So it doesn't necessarily suppress your estrogen levels in the same way that Letrozole does versus. **Dr. Nirali Jain:** Letrozole is an aromatase inhibitor, so it really blocks the chemical conversion of one drug or one hormone to the other hormone. Um, the reason we love Letrozole so much, and I don't mean to like gush over Letrozole, but um, it's a mono follicular agent, so it works really well at recruiting one follicle  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** you know, every OB-GYN's nightmare in a way is having multiples when you didn't intend on having multiples at all. **Michelle Oravitz:** so  **Dr. Nirali Jain:** Um. **Michelle Oravitz:** were saying that, um, there's more of a chance of twins, it's Clomid, not letrozole.  **Dr. Nirali Jain:** Yes, there's a higher chance with Clomid versus Letrozole. And I mean, don't get me wrong, there's a chance of twins with [00:13:00] any type of assisted reproductive technology. Even when we're doing single embryo transfers, there's a chance that it's gonna split. So, um, the chance is always there just like it is in the natural world. **Dr. Nirali Jain:** But we know for a fact that. CLO is really good at recruiting many follicles. It's good for certain patients that don't respond well to Letrozole. Um, but Letrozole is kind of our, our go-to drug these days just because of all the benefits that we've seen.  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** These are all fun things to ask because I, I love talking to our eis 'cause there's so much information that I'm always  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** learn a lot from my patients in my own research, but it's really cool. Picking your guys' brains. So another question I have, and I have actually talked to Dr. Andrea Elli, he's been on,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** and he does a lot of endometriosis and, and immune related work as well,  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** so. I'd love to know just from your perspective. One thing that I do know from, based on what I've heard is that the, [00:14:00] guess like you were just saying, that breast cancer or estrogen sensitive breast cancer doesn't seem to be affected by IVF cycles, however, and endometriosis lesions do get affected.  **Dr. Nirali Jain:** Yeah. **Dr. Nirali Jain:** that's a great question. So, you know, every, there are so many complex G mind diagnoses that the, that our patients come in with. Um, and endometriosis is a big one because there is clear data that endometriosis is linked to infertility. So we think about, you know, when a patient comes in with endometriosis, we really do think about the different treatment options and what are the short-term and long-term impacts of the hormones that we're giving 'em. **Dr. Nirali Jain:** Um, these days, again, kind of going back to Letrozole, we, letrozole is something that I give all of my endometriosis patients because it helps suppress their estrogen because we know.  **Michelle Oravitz:** interesting.  **Dr. Nirali Jain:** is very responsive to estrogen and leads to this dysfunctional regulation of all the endometrial tissue that can really flare in a, [00:15:00] in a cycle, or shortly after a cycle. **Dr. Nirali Jain:** I. So we really, for endometriosis patients, the, the best treatment is being on birth control because we don't see that hormonal fluctuation. The up and down of the estrogen and the progesterone, that's what leads to those flares. Um, so I really, I watch patients closely after their cycles too, because you definitely can have an endometriosis flare and we say the best treatment for endometriosis is pregnancy, right? **Dr. Nirali Jain:** That's when you're suppressed, that's when you're at your lowest. Um, and patients, my endo patients feel so good in pregnancy because they have. Hormones that are nice in that baseline, they're not getting periods of course. Um, and that's truly, truly the best treatment.  **Michelle Oravitz:** That's interesting.  **Dr. Nirali Jain:** But it is important to consider when you're going through infertility treatments. **Dr. Nirali Jain:** How does my endometriosis affect the short and long-term effects of the fertility medications? And really not to, not to say that they're bad in any way. I think a lot of endometriosis patients go through IVF and have success and do really, really well, and that's kind of the push that they need. [00:16:00] Um, but it's important to be mindful of the bigger picture here. **Dr. Nirali Jain:** It's not just, you're not just a number of. A patient with endo coming in, getting the same protocol. It's really individualized to the extent of your lesions, what symptoms you're having, what grade of endometriosis, where your lesions are. So we're the RAs are thinking about everything before we actually start your protocol. **Michelle Oravitz:** It's crazy how in depth it is, and it's, it, there's just so, it's so multifaceted,  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** when it's females  **Dr. Nirali Jain:** totally. **Michelle Oravitz:** are a little, I mean, they can, you know, there, there's definitely a number of things, but it's not as complicated and interconnected  **Dr. Nirali Jain:** Exactly. Exactly. That's so true. **Michelle Oravitz:** And so one question I actually have, this is kind of really off topic, but something that I was curious about. **Michelle Oravitz:** 'cause I heard about a while  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** a, a type of cancer treatment that was used. I'm not sure exactly what it was, but for some reason it actually caused follicles to grow, [00:17:00] or to multiply. And they were **Dr. Nirali Jain:** Interesting. **Michelle Oravitz:** this definitely. Puts, um, the whole idea of like a woman being born with all the follicles she'll ever have on its head, I thought that was really Interesting. **Michelle Oravitz:** Now I learned a little bit about it. I don't think it really went further than that,  **Dr. Nirali Jain:** Mm-hmm. **Michelle Oravitz:** one of those things that they're like, Hmm, this is interesting. I don't know, it was kind of a random side effect of this chemo drug. I dunno if it was a chemo drug or a cancer drug.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** ever heard of that. **Michelle Oravitz:** So I was just **Dr. Nirali Jain:** I haven't, I mean, that's interesting. I feel like I'd have to look into that because that would be definitely a point of interest for a lot of Reis. But it kind of does go back to the point of, you know, women are really born with all the eggs we're ever gonna have. So it's about a million, and then it just goes down from there. **Dr. Nirali Jain:** And the, by the time you start having periods, I like to kind of show my patients a chart, but you have a couple hundred thousand eggs and you ovulate one egg a month. That's, you know. Able to [00:18:00] progress into a fertilized egg and then into a, an embryo into a baby, um, if that's your goal. But otherwise, patients that are having periods and not trying to actually get pregnant, we're losing hundreds of eggs a month. **Dr. Nirali Jain:** So.  **Michelle Oravitz:** Mm.  **Dr. Nirali Jain:** It's important to kind of think about that decline, and it's important to know that that rate can be faster in patients with cancer, patients with low ovarian reserve. And sometimes when you have the two compounded, that's when a fertility specialist is definitely, you know, in the queue to, to have a discussion with you in terms of what that means and how you can reach your family building goals despite being faced with that, with that challenge. **Michelle Oravitz:** Yeah. **Michelle Oravitz:** I mean, 'cause we know oxidative stress is one of the things that can cause, uh,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** quality eggs, but it's also can cause cancer. **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** um, similar, you know, like things that really deplete the body could definitely impact. Um, and then what are your thoughts? I know I'm asking you all kinds of random questions, **Dr. Nirali Jain:** I love it. **Michelle Oravitz:** are your thoughts about doing low simulation in certain [00:19:00] circumstances versus high stem? **Michelle Oravitz:** Sometimes people don't respond as well to higher stems.  **Dr. Nirali Jain:** Yeah, that's a great point. I think that it kind of all goes back to creating an individualized protocol. If. A patient's going to a practice and basically just getting a protocol saying, this is our standard. We start with our standard of, you know, I, I think about the standard, which is 300 of the FSH or that pen that you dial up, and then 150 units of that powder vial. **Dr. Nirali Jain:** And we have patients mixing powders all the time, and that's kind of our blanket protocol that we give patients. But that's not really what's happening behind the scenes. And if you're given a protocol that's, and being told, you know, this is kind of what we give to everyone, it's probably not the right fit for you. **Michelle Oravitz:** Yeah, I  **Dr. Nirali Jain:** Um, there are certain patients that respond to a much lower dose and do really, really well, and then some patients that need a much higher dose. Um, and I think it's, that's kind of like the fun part of being an REI of being able to individualize the [00:20:00] protocol to the patient. Um, and I know for a fact there are so many, luckily, you know, we have so many leaders in REI that have been. **Dr. Nirali Jain:** Have dedicated their entire careers to researching these different protocols and how they can help different patients. Um, patients with lower a MH, you know, might benefit from a duo stim protocol, for example. That's kind of the first one that comes to mind, but a protocol where we're using those follicles from the second half of a cycle. **Dr. Nirali Jain:** I would've never thought that those were the follicles that  **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** would be better than the first half of the cycle,  **Michelle Oravitz:** Wait,  **Dr. Nirali Jain:** but, **Michelle Oravitz:** that. Explain that. Um, because I think that that's kind of a unique  **Dr. Nirali Jain:** mm-hmm.  **Michelle Oravitz:** that I haven't heard of.  **Dr. Nirali Jain:** Yeah, so there's this new day. It's still kind of developing, but um, kind of going back to, you know, what's an individualized protocol? Duo STEM is one of the newer protocols that we've started using. I, I've used it once or twice in patients. Um, but it goes back to the research that shows that you might actually have two different periods of time in a menstrual cycle where you could potentially recruit [00:21:00] follicles. **Dr. Nirali Jain:** You could have a follicular phase where there's a certain cohort of follicles recruited, and then you have a follicle that forms creates a corpus glut.  **Michelle Oravitz:** um, protocols  **Dr. Nirali Jain:** Yep. And then you basically go through the follicular protocol and then a few days after a retrieval, instead of waiting for a new follicular cohort or follicular recruitment from the first half of your menstrual cycle, you actually use the luteal phase and you recruit those follicles that would've actually died off or have been prematurely recruited in a prior cycle. **Dr. Nirali Jain:** So **Michelle Oravitz:** that's So  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** you just do a similar, I guess, um, medicine,  **Dr. Nirali Jain:** go right back into it.  **Michelle Oravitz:** do the same exact thing, but right after ovulation.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** Fascinating. That's really interesting.  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** has been your experience with that?  **Dr. Nirali Jain:** I think it's, honestly, it's mixed. Um, so far, you know, our data from fertility and sterility and A SRM, it, it shows support for these DUO STEM [00:22:00] protocols, saying that if patients don't have that great quality of eggs or if they have a very low number, maybe they'd benefit from starting the meds earlier and recruiting follicles. **Dr. Nirali Jain:** A little bit earlier. Um, so we've seen positive results so far. A lot of work to be done in terms of really understanding it. Um, and of course, as a new attending, I have a lot more experience to kind of build on. Um, but I, I have seen success from it. **Michelle Oravitz:** That's fascinating. Are there any other new technologies, like new add-ons, um, that you've seen, that you've found to be really cool or interesting?  **Dr. Nirali Jain:** I think the biggest thing, actually, kind of going back to our whole topic for today is fertility preservation cancer patients. One of the biggest things that I've learned recently is that we used to start fertility, um, patients. You know, only in the beginning of the cycle days, two or three is technically like when most. **Dr. Nirali Jain:** Most clinics, um, start patients, but for our cancer patients, sometimes you don't have that time. You don't wanna wait a full month to [00:23:00] restart, um, your, you know, your menstrual cycle and then do the fertility preservation and then delay chemotherapy a full month. So we started doing what we call random starts. **Dr. Nirali Jain:** So you basically start a patient whenever they come in. You know, it could be the day after your consultation, the day of your consultation. I've kind of seen all of the above. Um, and we've seen really good success with random starts, per se. Um, and we've been doing a lot more of that, where it's not as dependent on where you're at in your cycle. **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** Um, obviously there's a difference in outcomes. You might not be a great candidate for it, so definitely it's worth talking to your doctor about it. But it kind of gives relief to our cancer patients where if you have a new cancer diagnosis and you're like, oh, I just finished my period, like, I can't even start a cycle until next month. **Dr. Nirali Jain:** That's not always true. Um, so it's always worth it to go into see a fertility specialist and just get, you know, get the data that you need right away, and then you can make a decision later on. **Michelle Oravitz:** For sure. Um, Yeah. **Michelle Oravitz:** and I wanted to kind of cover a lot of different topics 'cause I know that [00:24:00] some people are gonna wanna hear what you have to say that don't necessarily, or, uh, have cancer. But it is important. I, I think that, you know, if you get to thirties and you haven't gotten married or you don't have a partner, I think it's really important to preserve your fertility in general.  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** important thing. And then if you were going through a cancer diagnosis and you decided to preserve your fertility, um, guess more for women because they're eventually going to be thinking about transfers after they go through treatment. So what are some of the things that they would need to consider as far as that goes? **Michelle Oravitz:** Like after the  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** then they go through the cancer treatments. Um, and then what, how long should they  **Dr. Nirali Jain:** yeah. Like what does it look like? So I've had patients that come back, you know, in my fellowship training I did a, a couple research projects on patients that came back to pursue an embryo transfer, um, after chemotherapy agent. And basically compared them to how they did, um, [00:25:00] compared to patients that didn't have cancer and just froze their embryos or froze their eggs and then came back to pursue a transfer and. **Dr. Nirali Jain:** I think the, the most reassuring thing from the preliminary data that we have is saying that there's no difference in pregnancy rates and no difference in life birth,  **Michelle Oravitz:** Awesome.  **Dr. Nirali Jain:** of whether they had chemotherapy or not. After freezing those eggs and going through fertility preservation.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Um, in terms of where your body needs to be, I think the oncologist, we, we wait for their green light. **Dr. Nirali Jain:** We wait for their signal to say, you know, she's safe to carry a pregnancy.  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** And then once we do that, we basically treat you like any other patient. So if you're coming in for a cycle, if you're having periods, then it's reasonable to try a natural cycle protocol, wait for your body to naturally ovulate an egg. **Dr. Nirali Jain:** And instead of obviously hoping that egg will fertilize, we, um, use a corpus luteum. We use the progesterone from the corpus luteum to really support this embryo being implanted into the uterus. Um. Yeah. [00:26:00] And then there's also another side. I mean, some patients don't get their periods back and they always ask like, what if I never get my period back? **Dr. Nirali Jain:** What if I'm just like in menopause because of the chemotherapy agents? And for that, we can start you on a synthetic protocol or basically an estrogen dependent protocol where you take an estrogen pill for a certain number of days. We monitor your lining, then we start progesterone, um, to support your hormones from that perspective instead of relying on your ovaries to release the progesterone that they need, um, and then doing the embryo transfer a few, few days after progesterone starts. **Dr. Nirali Jain:** So there's definitely different protocols depending on where your menstrual health is at after the chemotherapy or after the cancer treatment. Um, but it's important to kind of just know that. That there's options. It doesn't mean that it's the end of the road if you all of a sudden stop getting your period. **Michelle Oravitz:** Yeah, for sure. I mean, 'cause you, technically speaking, you can really control a lot of that. More so for transfers  **Dr. Nirali Jain:** Yep. **Michelle Oravitz:** Retrievals really is kind of like what [00:27:00] eggs you have, what the quality is. But people can be in complete menopause and you guys can still control their cycles for transfer, which is kind of. A huge difference  **Dr. Nirali Jain:** Yeah,  **Michelle Oravitz:** in the  **Dr. Nirali Jain:** exactly. That's exactly right. Yeah. **Michelle Oravitz:** interesting. Any other, um, new, new things that you're, you guys are excited about? I always like to hear about like the new and upcoming things  **Dr. Nirali Jain:** Of course.  **Michelle Oravitz:** actually before, which I thought was fascinating. Yeah.  **Dr. Nirali Jain:** I feel like there's always like updates and, and new data and things like that coming out, but just know, I think it's important for patients to know, like we're constantly, we're, the reason I chose to even pursue this field was because it's new. Right. There's something that we are discovering every day, every year, and that's what makes our, our conferences so important to attend, um, to really just stay up to date. **Dr. Nirali Jain:** Um, but we are, uh, constantly updating our embryology standards, the way we thaw our eggs, and the success rate associated with a thaw and [00:28:00] how we treat our embryos and the media that we use, right? Like, so we're really thinking about the basic science perspective every single day, and that's what makes this field so unique. **Michelle Oravitz:** It is really awesome. And so do you guys specialize specifically on, um. Egg freezing and, and I mean specific fertility preservation in patients that do that have cancer that are going through treatments, do you guys specialize specifically in that? I mean, I know you do range  **Dr. Nirali Jain:** Yeah. Yeah, because it's such a small community, we all have our own niches and we all kind of have our own interests and  **Michelle Oravitz:** Yeah.  **Dr. Nirali Jain:** no like specific training. There are a couple courses that you take that I took in in training as well, just to kind of understand what it sounds like to, I. Council of fertility preservation, patient with and without cancer. **Dr. Nirali Jain:** Um, and then, you know, you kind of just learn by experience and you form a niche for something that you're passionate about. 'cause that's what makes you, you know, really thorough in, in your treatment. [00:29:00] So that's one of my interests. Um, and, but I would say,  **Michelle Oravitz:** training for that. It's just like  **Dr. Nirali Jain:** yeah, **Michelle Oravitz:** just know how to treat that in  **Dr. Nirali Jain:** exactly.  **Michelle Oravitz:** especially if you're interested in doing that.  **Dr. Nirali Jain:** Exactly. That's exactly right. It's kind of, it just comes with the experience comes with your mentors and who you're surrounded by, and everyone kind of helps each other get to that point. But there are several specialists in our practice at RMA that specialize specifically in fertility preservation in cancer patients. **Dr. Nirali Jain:** So we have a close communication with our oncologist and they know who to refer to within the practice because everyone has their own little interests.  **Michelle Oravitz:** Amazing.  **Dr. Nirali Jain:** Yeah. **Michelle Oravitz:** Um, definitely. I, like I said, I really enjoy picking your brain because it's a lot of fun for me. I, I do  **Dr. Nirali Jain:** Totally.  **Michelle Oravitz:** acupuncture, so  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** and I, I think that it's just so crazy that our fields don't work together. I mean, we kind of do, but I think, I just feel like it would be so great  **Dr. Nirali Jain:** exactly.[00:30:00]  **Michelle Oravitz:** the expertise because you guys have immense. Benefits like in, in, uh, technology and incredible innovations and, and then the natural aspect of really understanding the, the body. And I, I just think that it would work so amazing together if it was more of like a thing. 'cause it, I know in China they actually combine the two  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** eastern.  **Dr. Nirali Jain:** Yeah, I mean I think that that's so important and there is data that shows, you know, there's actually a recent study that came out just a few weeks ago on the benefits of acupuncture for fertility patients. And we know that, I mean, I recommend it to all of my patients, specifically the day of the embryo transfer. **Dr. Nirali Jain:** We, luckily, we offer it on site at RMA and we have acupuncturists that come in and, and do a session before and after the embryo transfer, and I think. A lot of that is targeted towards stress relief. But I also think that holistically it's important to feel at your best when we're doing something that's so crucial to your, to your health. **Dr. Nirali Jain:** So to really focus on the diet, focus on stress relief, [00:31:00] focus on meditation, yoga, whatever it takes to get to your best wellbeing when you're going through fertility treatments, um, is so important. So I appreciate  **Michelle Oravitz:** Mm-hmm.  **Dr. Nirali Jain:** like you that really specialize in the other side of. Of this, because I do consider it still part of the holistic medicine that we need to really maximize success for our patients. **Michelle Oravitz:** Awesome. Well,  **Dr. Nirali Jain:** Yeah, **Michelle Oravitz:** Jane, this is such a pleasure Of talking to you. You've given us some, so much great information and we've definitely dived into a, do a topic that I don't typically, I haven't yet spoken about. But, um, that being said, it's such an important topic to talk about. And thank you so much for coming on today. **Michelle Oravitz:** Oh,  **Dr. Nirali Jain:** course. **Michelle Oravitz:** I get off, how can people find you?  **Dr. Nirali Jain:** That's a great question. So I have, um, a social media page. I, it's called Expert nc. So like EGG,  **Michelle Oravitz:** I  **Dr. Nirali Jain:** um, expert nc. Try, tried to make it a little bit humorous. Um, but I'm all over social [00:32:00] media and would love to hear from anyone that is listening. I, you know, every, every day I get different, um, dms and I'm happy to respond. **Dr. Nirali Jain:** I love hearing about everyone else's. Stories and things like that. Um, so that is kind of my main, main social media platform. Um, and then through like RMA and Reproductive Medical Associates, we also have a YouTube channel. We have an Instagram page, um, of our office available, um, as well that is public. **Dr. Nirali Jain:** So you can find us pretty easily if you just kind of hit Google. But um, yeah, I'm kind of developing my social media platform as the expert and I hope it grows.  **Michelle Oravitz:** Love it. Great.  **Dr. Nirali Jain:** Yeah.  **Michelle Oravitz:** was such a pleasure talking to you. Thank you. so much **Dr. Nirali Jain:** Thank you. **Michelle Oravitz:** today.  **Dr. Nirali Jain:** Of course. Thank you so much for having me.  [00:33:00]   

Employee turnover is expensive—and preventable. In this episode of Behind The Numbers With Dave Bookbinder, we're tackling the hidden costs of turnover and the ROI of investing in your people. Dave is joined by Francie Jain, founder of Terawatt, a B2B marketplace for group coaching that Francie describes as “Airbnb for executive coaching.” Francie unpacks how scalable group coaching can help organizations drive learning, build psychological safety, and improve employee retention. The conversation explores the measurable and intangible impacts of turnover and burnout—and why professional development is the key to tackling both. You'll learn: How to calculate ROI on learning and development initiatives Why burnout is an organizational issue—not just an individual one Real-world examples of how coaching drives financial and cultural gains How leaders can foster engagement, empowerment, and better communication If you're looking for actionable ways to improve employee experience while improving your bottom line, this episode is for you. ----more----About Francie Jain: Francie Jain believes supporting people to achieve their potential creates a ripple effect for every community. After a career in alternative asset marketing (match-making for hedge funds), she became obsessed with the lack of professional support for individuals at crossroads. She founded Terawatt to make it easy to be great.   Terawatt is Francie's third for-profit endeavor. Before Terawatt, Francie founded a community that helped people with career change, Nxt Chptr, and prior to Nxt Chptr, a third party marketing consultancy, West River Partners, that raised capital for Emerging Markets-based equity hedge funds. About the Host: Dave Bookbinder is known as an expert in business valuation and he is the person that business owners and entrepreneurs reach out to when they need to know what their most important assets are worth. Known as a collaborative adviser, Dave has served thousands of client companies of all sizes and industries.  Dave is the author of two #1 best-selling books about the impact of human capital (PEOPLE!) on the valuation of a business enterprise called The NEW ROI: Return On Individuals & The NEW ROI: Going Behind The Numbers.  He's on a mission to change the conversation about how the accounting world recognizes the value of people's contributions to a business enterprise, and to quantify what every CEO on the planet claims: “Our people are this company's most valuable asset.” Dave's book, A Valuation Toolbox for Business Owners and Their Advisors: Things Every Business Owner Should Know, was recognized as a top new release in Business and Valuation and is designed to provide practical insights and tools to help understand what really drives business value, how to prepare for an exit, and just make better decisions. He's also the host of the highly rated Behind The Numbers With Dave Bookbinder business podcast which is enjoyed in more than 100 countries.

Send us a textFarming the Revolution captures a mass movement in vivid close-up, as 12 million farmers challenge the Indian government, forcing it to retract its unjust farm laws. Farming the Revolution will be screening at this year's Sydney Film Festival (SFF) on June 5th & 7th. This film is also a part of Collection: Focus on Nishta Jain screening The Golden Thread and Gulabi Gang.Note: this interview is audio only. For other video interviews check out our YouTube playlist.Website | Rotten Tomatoes | Linktree | Youtube | Twitter | Instagram